Mylan pays $17.5 million for Pfizer’s copy of Advair
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
- Alzecure enters collaboration and with Lilly for Alzheimer’s project
- Survodutide trial data show targeted visceral and liver fat reductions
- Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity
- European approval enables measles protection with CSL’s immunoglobulin Privigen
